HB370 (2024) Compare Changes


Unchanged Version

Text to be removed highlighted in red.

48:1 Tinted Glass. Amend RSA 266:58-a, III-a to read as follows:

III-a. Persons who require for medical reasons after market tinting on the windshield may apply for a special permit pursuant to RSA 266:61-a, IX.

48:2 Equipment Waiver for Disabled. Amend RSA 266:61-a to read as follows:

IX. The commissioner may waive the requirements of RSA 266:58-a and issue a special permit to a person who for bona fide medical reasons requires after market tinting on the windshield and who applies for such permit. Such waiver shall be granted in accordance with this section and shall only authorize the use of after market tinted windows with a light transmittance of not less than 70 percent. In reviewing the application for a permit under this paragraph, the commissioner may seek the advice and recommendation of a medical review board designated by him or her for such purpose.

48:3 Effective Date. This act shall take effect 90 days after its passage.

Approved: June 14, 2024

Effective Date: September 12, 2024

Changed Version

Text to be added highlighted in green.

48:1 Tinted Glass. Amend RSA 266:58-a, III-a to read as follows:

III-a. Persons who require for medical reasons after market tinting on the windshield or on the windows to the left and right of the driver may apply for a special permit pursuant to RSA 266:61-a, IX.

48:2 Equipment Waiver for Disabled. Amend RSA 266:61-a to read as follows:

IX. The commissioner may waive the requirements of RSA 266:58-a and issue a special permit to a person who for bona fide medical reasons requires after market tinting on the windshield or on the windows to the left and right of the driver and who applies for such permit. Such waiver shall be granted in accordance with this section and shall only authorize the use of after market tinted windows with a light transmittance of not less than 35 percent. In reviewing the application for a permit under this paragraph, the commissioner may seek the advice and recommendation of a medical review board designated by him or her for such purpose.

48:3 Effective Date. This act shall take effect 90 days after its passage.

Approved: June 14, 2024

Effective Date: September 12, 2024